Seed+ · Biotech
Psilera: Seed+
Develops next-generation neuroplastogens and psychedelic therapies for neurological conditions
Funding history
Seed+ · This round$8.8M
Develops next-generation neuroplastogens and psychedelic therapies for neurological conditions